Selected research
Industry Growth & Trends
Global Human Blood Products Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Human Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Human Blood Products market include Biotest, BPL, CSL, Grifols, Kedrion, KM Biologics, LFB Group, Octapharma and Boya Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Human Blood Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Human Blood Products market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Blood Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Blood Products.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Human Blood Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Human Blood Products Market by Company
Biotest
BPL
CSL
Grifols
Kedrion
KM Biologics
LFB Group
Octapharma
Boya Bio
Hualan Bio
Nanyue Bio
RAAS
Shuanglin Bio
CBPO
Tiantan Bio
Weiguang Bio
Takeda
Yuanda Shuyang
Human Blood Products Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Human Blood Products Segment by Application
Hospital
Retail Pharmacy
Other
Human Blood Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Human Blood Products companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Immune Globulin
- Coagulation Factor
- Albumin
- Other
Applications
- Hospital
- Retail Pharmacy
- Other
Companies covered
- Biotest
- BPL
- CSL
- Grifols
- Kedrion
- KM Biologics
- LFB Group
- Octapharma
- Boya Bio
- Hualan Bio
- Nanyue Bio
- RAAS
- Shuanglin Bio
- CBPO
- Tiantan Bio
- Weiguang Bio
- Takeda
- Yuanda Shuyang
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Human Blood Products Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Human Blood Products Market Size by Region (2021-2032)
- 1.4.1 Global Human Blood Products Market Size by Region (2021-2026)
- 1.4.2 Global Human Blood Products Market Size by Region (2027-2032)
- 1.5 Key Regions Human Blood Products Market Size (2021-2032)
- 1.5.1 North America Human Blood Products Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Human Blood Products Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Human Blood Products Market Size Growth Rate (2021-2032)
- 1.5.4 South America Human Blood Products Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Human Blood Products Market Size Growth Rate (2021-2032)
2 Human Blood Products Market by Type
- 2.1 Type Introduction
- 2.1.1 Immune Globulin
- 2.1.2 Coagulation Factor
- 2.1.3 Albumin
- 2.1.4 Other
- 2.2 Global Human Blood Products Market Size by Type
- 2.2.1 Global Human Blood Products Market Size Overview by Type (2021-2032)
- 2.2.2 Global Human Blood Products Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Human Blood Products Market Size Forecasted by Type (2027-2032)
- 2.3 Global Human Blood Products Market Size by Regions
- 2.3.1 North America Human Blood Products Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Human Blood Products Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Human Blood Products Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Human Blood Products Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Human Blood Products Market Size Breakdown by Type (2021-2026)
3 Human Blood Products Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Retail Pharmacy
- 3.1.3 Other
- 3.2 Global Human Blood Products Market Size by Application
- 3.2.1 Global Human Blood Products Market Size Overview by Application (2021-2032)
- 3.2.2 Global Human Blood Products Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Human Blood Products Market Size Forecasted by Application (2027-2032)
- 3.3 Global Human Blood Products Market Size by Regions
- 3.3.1 North America Human Blood Products Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Human Blood Products Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Human Blood Products Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Human Blood Products Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Human Blood Products Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Human Blood Products Industry Trends
- 4.2 Human Blood Products Industry Drivers
- 4.3 Human Blood Products Industry Opportunities and Challenges
- 4.4 Human Blood Products Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Human Blood Products Revenue (2021-2026)
- 5.2 Global Human Blood Products Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Human Blood Products Key Company Headquarters & Area Served
- 5.4 Global Human Blood Products Company, Product Type & Application
- 5.5 Global Human Blood Products Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Human Blood Products Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Human Blood Products Players Market Share by Revenue in 2025
- 5.6.3 2025 Human Blood Products Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Biotest
- 6.1.1 Biotest Company Information
- 6.1.2 Biotest Business Overview
- 6.1.3 Biotest Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Biotest Human Blood Products Product Portfolio
- 6.1.5 Biotest Recent Developments
- 6.2 BPL
- 6.2.1 BPL Company Information
- 6.2.2 BPL Business Overview
- 6.2.3 BPL Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 BPL Human Blood Products Product Portfolio
- 6.2.5 BPL Recent Developments
- 6.3 CSL
- 6.3.1 CSL Company Information
- 6.3.2 CSL Business Overview
- 6.3.3 CSL Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 CSL Human Blood Products Product Portfolio
- 6.3.5 CSL Recent Developments
- 6.4 Grifols
- 6.4.1 Grifols Company Information
- 6.4.2 Grifols Business Overview
- 6.4.3 Grifols Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Grifols Human Blood Products Product Portfolio
- 6.4.5 Grifols Recent Developments
- 6.5 Kedrion
- 6.5.1 Kedrion Company Information
- 6.5.2 Kedrion Business Overview
- 6.5.3 Kedrion Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Kedrion Human Blood Products Product Portfolio
- 6.5.5 Kedrion Recent Developments
- 6.6 KM Biologics
- 6.6.1 KM Biologics Company Information
- 6.6.2 KM Biologics Business Overview
- 6.6.3 KM Biologics Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 KM Biologics Human Blood Products Product Portfolio
- 6.6.5 KM Biologics Recent Developments
- 6.7 LFB Group
- 6.7.1 LFB Group Company Information
- 6.7.2 LFB Group Business Overview
- 6.7.3 LFB Group Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 LFB Group Human Blood Products Product Portfolio
- 6.7.5 LFB Group Recent Developments
- 6.8 Octapharma
- 6.8.1 Octapharma Company Information
- 6.8.2 Octapharma Business Overview
- 6.8.3 Octapharma Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Octapharma Human Blood Products Product Portfolio
- 6.8.5 Octapharma Recent Developments
- 6.9 Boya Bio
- 6.9.1 Boya Bio Company Information
- 6.9.2 Boya Bio Business Overview
- 6.9.3 Boya Bio Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Boya Bio Human Blood Products Product Portfolio
- 6.9.5 Boya Bio Recent Developments
- 6.10 Hualan Bio
- 6.10.1 Hualan Bio Company Information
- 6.10.2 Hualan Bio Business Overview
- 6.10.3 Hualan Bio Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Hualan Bio Human Blood Products Product Portfolio
- 6.10.5 Hualan Bio Recent Developments
- 6.11 Nanyue Bio
- 6.11.1 Nanyue Bio Company Information
- 6.11.2 Nanyue Bio Business Overview
- 6.11.3 Nanyue Bio Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Nanyue Bio Human Blood Products Product Portfolio
- 6.11.5 Nanyue Bio Recent Developments
- 6.12 RAAS
- 6.12.1 RAAS Company Information
- 6.12.2 RAAS Business Overview
- 6.12.3 RAAS Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 RAAS Human Blood Products Product Portfolio
- 6.12.5 RAAS Recent Developments
- 6.13 Shuanglin Bio
- 6.13.1 Shuanglin Bio Company Information
- 6.13.2 Shuanglin Bio Business Overview
- 6.13.3 Shuanglin Bio Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Shuanglin Bio Human Blood Products Product Portfolio
- 6.13.5 Shuanglin Bio Recent Developments
- 6.14 CBPO
- 6.14.1 CBPO Company Information
- 6.14.2 CBPO Business Overview
- 6.14.3 CBPO Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 CBPO Human Blood Products Product Portfolio
- 6.14.5 CBPO Recent Developments
- 6.15 Tiantan Bio
- 6.15.1 Tiantan Bio Company Information
- 6.15.2 Tiantan Bio Business Overview
- 6.15.3 Tiantan Bio Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Tiantan Bio Human Blood Products Product Portfolio
- 6.15.5 Tiantan Bio Recent Developments
- 6.16 Weiguang Bio
- 6.16.1 Weiguang Bio Company Information
- 6.16.2 Weiguang Bio Business Overview
- 6.16.3 Weiguang Bio Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Weiguang Bio Human Blood Products Product Portfolio
- 6.16.5 Weiguang Bio Recent Developments
- 6.17 Takeda
- 6.17.1 Takeda Company Information
- 6.17.2 Takeda Business Overview
- 6.17.3 Takeda Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Takeda Human Blood Products Product Portfolio
- 6.17.5 Takeda Recent Developments
- 6.18 Yuanda Shuyang
- 6.18.1 Yuanda Shuyang Company Information
- 6.18.2 Yuanda Shuyang Business Overview
- 6.18.3 Yuanda Shuyang Human Blood Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Yuanda Shuyang Human Blood Products Product Portfolio
- 6.18.5 Yuanda Shuyang Recent Developments
7 North America
- 7.1 North America Human Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Human Blood Products Market Size by Country (2021-2026)
- 7.3 North America Human Blood Products Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Human Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Human Blood Products Market Size by Country (2021-2026)
- 8.3 Europe Human Blood Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Human Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Human Blood Products Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Human Blood Products Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Human Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Human Blood Products Market Size by Country (2021-2026)
- 10.3 South America Human Blood Products Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Human Blood Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Human Blood Products Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Human Blood Products Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst